Session date: 
Friday, May 11, 2018 - 12:00pm to 1:00pm
Pathology Conference Room 247
9200 W Wisconsin Avenue, WDL Building, Second Floor
Milwaukee, WI 53226
United States
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Please login or register to take this course.
Program Description: 

This educational activity is designed to provide our faculty with alternative sources of information and experience on controversial areas in diagnostic pathology that cannot be gleaned from reading the literature or standard textbooks in pathology.  There are many areas in pathology where a uniformly acceptable standard has not yet been established.  Direct interaction with an expert can provide the pathologist with additional insight into more effective ways to handle the issue. 


ACCME Accreditation Statement:

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


AMA Credit Designation:

The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Hours of Participation for Allied Health Professionals:

The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target audience: 
Physician's Assistants
Learning objectives: 

At the conclusion of this activity, learners will be able to:

  • Discuss recent molecular genetic advances in selected bone and soft tissue tumors and relevant genotype-phenotype correlations
  • Review novel diagnostic markers that have been developed secondart to these genetic insights, including their specific diagnostic utility, limitations and pitfalls
  • Understand how molecular/genetic insights have led to the refinement of classification of specific entities and the recognition of novel tumor types
Faculty & credentials: 
Planning Committee:
Saul Suster, MD
Vickie Y Jo, MD
Assistant Profesor of Pathology, Harvard Medical School
Associate Pathologist, Brigham and Women's Hospital
Consultant, Dana Farber Cancer Institute

All persons in control of content have NO relevant financial relationships to disclose with the exception of the following and in accordance with the ACCME® standards for Commercial Support Number 6, these relationships were reviewed via the MCW conflict of interest resolution process and resolved.

Vickie Y Jo, MDMerckSpouse is Employed by Aforementioned



Shannon Majewski
Phone number: 
+1 (414) 805-6976